Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2100
-0.0040 (-1.87%)
Apr 3, 2025, 3:59 PM EST

Northwest Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2903648228306631,255
Upgrade
Market Cap Growth
-55.72%-55.72%-1.00%25.14%-47.13%870.89%
Upgrade
Enterprise Value
3714358818656861,270
Upgrade
Last Close Price
0.210.270.700.780.701.52
Upgrade
PE Ratio
----3.70-
Upgrade
PS Ratio
192.45263.35425.38493.23660.04971.84
Upgrade
PB Ratio
-4.61-4.61-17.47-7.90-5.35-3.46
Upgrade
EV/Sales Ratio
268.50314.92455.93513.96682.10983.37
Upgrade
Debt / Equity Ratio
-0.85-0.85-0.97-0.25-0.31-0.05
Upgrade
Asset Turnover
0.050.050.070.050.030.06
Upgrade
Quick Ratio
0.030.030.050.060.110.03
Upgrade
Current Ratio
0.060.060.090.080.130.04
Upgrade
Return on Assets (ROA)
-152.28%-152.28%-117.23%-117.48%-90.17%-248.63%
Upgrade
Earnings Yield
-28.86%-23.02%-7.62%-12.65%27.00%-42.23%
Upgrade
FCF Yield
-19.99%-15.95%-6.94%-6.71%-6.68%-3.08%
Upgrade
Buyback Yield / Dilution
-10.99%-10.99%-10.17%-0.79%-38.99%-28.53%
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.